Dr Nick Scott is an Econometrician at the Burnet Institute. He uses mathematical and economic models to generate evidence for the most effective hepatitis elimination strategies.

Kerrin Param has worked most of her career in community with 10 years in Alcohol and Other Drug Service Far North Queensland and Fraser Coast. Community involvement contributed to outcomes. Kerrin commenced work with Sunshine Coast University Hospital and Hepatology Partnership mid 2017.

Maria McMahon has worked in the BBV/STI sector with sex worker, HIV and viral hepatitis community based organisations for 25 years and is currently engaged as the Deputy CEO of Hepatitis NSW.

Brad Whitton is a hepatitis clinical nurse consultant with Alfred Health, Melbourne, Australia. He works in hospital outpatient departments and provides an outreach service to multiple community, primary health and general practice settings across Melbourne. He has many years of experience working in the HIV, Sexual Health and Hepatitis sector.

Alisa Pedrana is public health practitioner and senior research fellow at Burnet Institute. Her research career has focussed on Blood-borne virus/Sexually Transmitted Infections epidemiology and surveillance to inform prevention practice and policy. With a strong emphasis on research translation, her current work on Hepatitis C elimination is focussed on implementation science to strengthen health systems, enhance health service delivery and develop sustainable models of care.

Dr Doyle is an infectious diseases physician at the Alfred Hospital in Melbourne.

I am a second-year PhD candidate (Scientia Scholar) at The Kirby Institute, University of New South Wales, Australia. My PhD project aims to assess the feasibility of rapid scale-up of DAA therapy and its impact on the proportion with HCV viraemia among HIV-HCV population in Australia.

Jo Holden is the Director, Population Health Strategy and Performance in the Centre for Population Health at the NSW Ministry of Health. She is responsible for the implementation of state-wide targets within the NSW HIV, sexually transmissible infection and viral hepatitis strategies and policy, system and governance reform across NSW.

Stelliana is a third year PhD student. Her thesis explores the personal level benefits of direct-acting antiviral treatment for hepatitis C. She is interested in quality of life, health behaviours and the treatment experience.

Dr Kwon uses mathematical models and health economics to evaluate the effectiveness and cost- effectiveness of past prevention and/or clinical programs. She is working at the Kirby Institute, UNSW, leading CV projections and estimations project in Australia.

Sichan He is a PhD student at The Kirby Institute, UNSW Sydney.

Rebecca is a clinical nurse consultant at the Kirketon Road Centre and the Hepatitis C Treatment coordinator